<?xml version="1.0" encoding="UTF-8"?>
<p>Obesity, overweightness, diabetes, and dyslipidemia are global health problems with increasing prevalence [
 <xref rid="B37-molecules-26-02831" ref-type="bibr">37</xref>]. Many scientific reports have found that they are directly associated with an increase in mortality rates of cancer and cardiovascular, respiratory, hepatic, and renal diseases [
 <xref rid="B38-molecules-26-02831" ref-type="bibr">38</xref>]. In the last three decades, in Palestine and many other countries, the high prevalence of these metabolic disorders has been obvious and worrisome [
 <xref rid="B39-molecules-26-02831" ref-type="bibr">39</xref>]. In fact, any pharmacological agent that can inhibit the actions of the vital metabolic enzymes, including lipase, α-amylase, and α-glucosidase, can inevitably cure these life-threatening disorders [
 <xref rid="B40-molecules-26-02831" ref-type="bibr">40</xref>]. Actually, in various ethnopharmacological global systems of medicine, aromatic plants have long been utilized for the treatment of obesity, overweightness, dyslipidemia, and diabetes [
 <xref rid="B41-molecules-26-02831" ref-type="bibr">41</xref>,
 <xref rid="B42-molecules-26-02831" ref-type="bibr">42</xref>].
</p>
